2Towne AR, Pellock JM, Ko D, et al. Determinants of mortality in status epilepticus[J]. Epilepsia, 1994,35: 27-34.
3DeLorenzo pal, Sombati S, Coulter DA. Effects of topiramate on sustained repetitive firing and spontaneous recurrent seizure discharges in cultured hippocampal neurons[J]. Epilepsia, 2000,41: 40-44.
4White HS, Brown SD, Woodhead JH, et al. Topiramate modulates GABA-evokod eun~nts in murine cortical neurons by a nonbenzodiazepine mechanism[J]. Epilepsia, 2000, 41:17 - 20.
5Petroff OA, Hyder F, Rothman DL, et aL Topiramate rapidly raises brain GABA in epilepsy patients[J]. Epilepsia, 2001, 42:543 - 548.
6Gibbs JW, Sombati S, DeLorenzo Pj, et al. Cellular actions of topiramate: blockade of kainate-evoked inward cunents in cultured hippocampal neurons[J]. Epilepsia, 2000,41: 10- 16.
7Zhang X, Velumian AA, Jones OT, et al. Modulation of high-voltage-activated calcium channels in dentate granule cells by topiramate[J]. Epilepsia, 2000,41: 52-60.
8Niebauer M, Gruenthal M. Topiramate reduces neuronal injury after experimental status epilepticus [ J ]. Brain Res, 1999,837:263 - 269.
二级参考文献10
1Easterling DE, Zakszewski T, Moter MD, et al. Plasma pharmacokinetics of topiramate,a new anticonvulsant in humans. Epilepsia,1988,29: 662
2Faught E,Wilder BJ, Ramsay RE, et al. Topiramate placebo-controlled dose-renging trial in refractory partial epilepsy using 200-,400-,and 1000-mg daily dosage. Neurology, 1996, 46:1684
3Brodie MJ, Biton V, Montouis GD, et al. Topiramate therapy in patients with generalized tonic-clonic seizures with or without focal onset: Long-term outcome. Epilepsia, 1998,39(Suppl. 2): 2
4Ritter FJ, Glauser TA, Sachdeno RC, et al. Long-term experince with topiramate in Lennox- Gastaut syndrome. Epilepsia, 1998,39(Suppl. 2): 2
5Glauser TA, Elterman R, Wyllic E, et al. Open-label topiramate in pediatric partial epilepsy. Epilepsia, 1997, 38(Suppl. 3):94
6Ben-menachem E. Exp. Opin. Invest. Durgs, 1997,6: 1085
7Sachdeo RC, Sachdeo SK,Walker SA,et al.Steadystate pharmacokinetics of topiramate and carbamazepine in papients with epilepsy during monotherapy and concommitant therapy. Epilepsia, 1996,37: 774
8Rosenfeld WE, Liao S, Kramer LD,et al.Comparison of the steady-state pharmacokinetics of topiramate and valproate in patients with epilepsy during monotherapy and concommitant therapy. Epilepsia, 1997, 38:324
9Shorvon SD. Safety of topiramate: adverse events and relationships to dosing. Epilepsia, 1996, 37(Suppl.2):S 18
10Reife RA, Lim P, Pledger G. Topiramate: side-effect profile in double-blind studies.Epilepsia, 1995, 36(Suppl.4): 34
4OrtinskiP, MeadorKJ. Cognitive side effects ofantiepileptic drugs[J]. Epilepsy Behav,2004,5(Suppl. 1):S60-65.
5龚耀先.中国修订韦氏记忆量表手册[M].长沙:湖南医学院,1982:1-30.
6Mori Y, Kurosu S, Hirogama Y, et al. Prolongation of P3001atency is associated with the durationn of illness in maleschizophrenia patients [J]. Psychiatry and Clinical Neuroseiences, 2007,61 (5) : 471-478.
7Meador KJ,Loring DW,Vahle VJ,et al. Cognitive and behavioral effects of lamotrigine and topiramate in healthy volunteers[J]. Neurology, 2005,64(12) : 2108-2114.
8Fritz N,Glogau S,Hoffmann J,et al. Efficacy and cognitive side effects of tiagabine and topiramate in patients with epilepsy[J]. Epilepsy & Behavior,2005,6(3):373- 381.
9Salinsky M,Storzbach D,Oken B,et al. Topiramate effects on the EEG and alertness in healthy volunteers:A different profile of antiepileptic drug neurotoxicity[J]. Epilepsia, 2007,10 (3) : 463-469.
10Salinsky MC,Storzbach D,Spencer DC,et al. Effects of topiramate and gabapentin on cognitive abilities in heahhy volunteers [ J ]. Neurology, 2005,64 (5) : 792-798.
